title: Successful treatment of refractory esophageal Crohn's disease with infliximab.
authors.forename: D S
authors.initials: DS
authors.lastname: Fefferman
authors.forename: S A
authors.initials: SA
authors.lastname: Shah
authors.forename: M
authors.initials: M
authors.lastname: Alsahlil
authors.forename: A
authors.initials: A
authors.lastname: Gelrud
authors.forename: K R
authors.initials: KR
authors.lastname: Falchulk
authors.forename: R J
authors.initials: RJ
authors.lastname: Farrell
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003424:Crohn Disease / Q000175:diagnosis / Q000188:drug therapy*; D004935:Esophageal Diseases / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D005765:Gastrointestinal Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab